Company profile: Advanced Analytical Technologies
1.1 - Company Overview
Company description
- Provider of high-throughput, fully-automated nucleic acid and genetic analysis systems for commercial and research applications, designed to improve processes in the molecular diagnostics, pharmaceutical, life science, agricultural, and biofuels industries.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Advanced Analytical Technologies
Nektar Therapeutics
HQ: United States
Website
- Description: Provider of therapeutics based on an advanced polymer conjugate chemistry platform, including Rezpegaldesleukin (REZPEG/NKTR-358), a regulatory T cell stimulator targeting the IL-2 receptor complex to address immune imbalances in autoimmune and inflammatory diseases; PEG-CSF Protein to modulate inflammation resolution; and a bivalent TNFR antibody that selectively stimulates TNFR2 to enhance T regulatory cell function.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nektar Therapeutics company profile →
Singulex
HQ: United States
Website
- Description: Provider of direct molecular detection and cardiovascular monitoring solutions, including the Singulex Clarity System, an automated in vitro diagnostics platform using Single Molecule Counting technology for precise, ultra-low-level biomarker measurement across a 6-log reporting range, and the Singulex cTnI Assay for femtogram-per-milliliter cardiac troponin I quantitation to aid cardiovascular disease diagnosis and management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Singulex company profile →
Molecular Devices
HQ: United States
Website
- Description: Provider of analytical solutions for cell and protein biology, enabling customers to unravel complex biological systems. Offerings include AI-driven automated cell culture (CellXpress.ai), high-content confocal imaging (ImageXpress), SpectraMax microplate readers, SoftMax Pro software for data analysis, GxP compliance solutions, and an Organoid Innovation Center for 3D biological models.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Molecular Devices company profile →
Reach Separations
HQ: United Kingdom
Website
- Description: Provider of chiral and achiral separation services, discovery chromatography, large-scale SFC, impurity isolations, and analytical services, including EE determinations; purification of hundreds of grams of racemate using preparative HPLC/SFC and large-scale SFC with automated screening and evaporation; LC-MS/SFC-MS method development, orthogonal purity analysis, multi-component resolutions, reference standard generation; MS-MS/NMR elucidation; QC purity checks and stability studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reach Separations company profile →
Complete Genomics
HQ: United States
Website
- Description: Provider of DNA sequencing platforms for human genome sequencing and analysis, supporting commercial-scale research into genetic mechanisms underlying drug responses and complex diseases. Offerings include DNBSEQ-T7 and DNBSEQ-T20x2 ultra-high throughput sequencers, DNBSEQ-G400 high throughput, DNBSEQ-G99 fast mid throughput, DNBSEQ-E25 portable, and CoolMPS for genomic analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Complete Genomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Advanced Analytical Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Advanced Analytical Technologies
2.2 - Growth funds investing in similar companies to Advanced Analytical Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Advanced Analytical Technologies
4.2 - Public trading comparable groups for Advanced Analytical Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →